Improving cell transplantation after spinal cord injury: When, where and how?June 01, 2016
Spinal cord injuries are mostly caused by trauma, often incurred in road traffic or sporting incidents, often with devastating and irreversible consequences, and unfortunately having a relatively high prevalence (250,000 patients in the USA; 80% of cases are male). One currently explored approach to restoring function after spinal cord injury is the transplantation of olfactory ensheathing cells (OECs) into the damaged area. The hope is that these will encourage the repair of damaged neurons, but does it work? And if so, how can it be optimized?
According to a systematic analysis of the literature published this week in PLOS Biology, after experimental spinal cord injury, transplanting OECs into the site of damage does indeed significantly improve locomotor performance. To reach this conclusion, Ralf Watzlawick, Jan Schwab, and their colleagues at the Ohio State University Wexner Medical Center, CharitÃ© Universtaetsmedizin Berlin and the CAMARADES consortium (Collaborative Approach to Meta Analysis and Review of Animal Data from Experimental Studies), analyzed 49 studies, published between 1949 and 2014, which included 62 experiments involving 1164 animals.
Restoration of function after spinal cord injury remains one of the most formidable challenges in regenerative medicine, but cell transplantation into the spinal cord represents a promising treatment strategy. OECs are considered particularly suitable for transplantation because they have been shown to be neuro-protective and to promote neuro-regeneration in different settings, and can be extracted from the patient's own nasal cavity, thereby minimizing the chances of graft rejection and avoiding the need for immunosuppressive drugs.
However, reports in the literature about the efficacy of transplantation of OECs for treatment of spinal cord injury have been contradictory. Therefore, to investigate the in vivo evidence for the efficacy of this procedure, the authors implemented a systematic review and meta-analysis of the literature. Importantly, the authors set out to explore the potential influence of variations in experimental approaches and unreported data.
"We felt that after more than two decades since the discovery that OECs elicit effects on neural plasticity in vivo, it was time to test their effects by appropriate methodology beyond reproduction", the authors argued.
The data analysed by the authors justify the use of OECs as a cellular substrate to develop and to optimize minimally invasive and secure protocols for repairing damaged spinal cord. They also identified several aspects of the cell transplantation procedure that could have a significant impact on the size of the therapeutic effect, including: the time-point of application, the use of surgical micro-dissection to "refresh" the scar tissue, the localization of transplanted cells, the number of injections, the injected volume, and the dose of cells administered.
Importantly, by using state-of-the-art statistical methods the authors also found that the impact of publication bias (due to selective failure to report results) was minimal, further supporting the translational potential of this approach.
Despite being focussing on OECs, the findings may be of more general relevance for optimizing the transplantation of other cell types after spinal cord injury.
The Collaborative Approach to Meta Analysis and Review of Animal Data from Experimental Studies.
In your coverage please use this URL to provide access to the freely available article in PLOS Biology: http://dx.plos.org/10.1371/journal.pbio.1002468
Citation: Watzlawick R, Rind J, Sena ES, Brommer B, Zhang T, Kopp MA, et al. (2016) Olfactory Ensheathing Cell Transplantation in Experimental Spinal Cord Injury: Effect size and Reporting Bias of 62 Experimental Treatments: A Systematic Review and Meta-Analysis. PLoS Biol 14(5): e1002468. doi:10.1371/journal.pbio.1002468
Funding: RW was sponsored by the "Studienstiftung des deutschen Volkes" (#186392). JMS received funding support from the Else-Kroehner-Fresenius Foundation, the Wings-for-Life Spinal Cord Research Foundation (#60-2012), and the W.E. Hunt & C.M. Curtis Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Related Spinal Cord Injury Current Events and Spinal Cord Injury News Articles
Simple attraction: Researchers control protein release from nanoparticles without encapsulation
A U of T Engineering team has designed a simpler way to keep therapeutic proteins where they are needed for long periods of time. The discovery is a potential game-changer for the treatment of chronic illnesses or injuries that often require multiple injections or daily pills.
Drug used for pain, anxiety may be linked to birth defects
A drug commonly used to treat pain, epilepsy, anxiety and other brain health disorders may be associated with an increased risk of major birth defects, according to a study published in the May 18, 2016, online issue of NeurologyÂ®, the medical journal of the American Academy of Neurology.
Research findings reveal potential to reverse cancer-related nerve pain
A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment.
Double-blinded randomized controlled trial of the Xiao procedure in children
Researchers at Johns Hopkins All Children's Hospital report the results of a double-blinded randomized controlled trial of the "Xiao procedure" in children with spina bifida.
Researchers find possible treatment for suppressed immunity from spine injuries
Scientists report in Nature Neuroscience they have identified an underlying cause of dangerous immune suppression in people with high level spinal cord injuries and they propose a possible treatment.
Immune cells help the brain to self-heal after a stroke
After a stroke, there is inflammation in the damaged part of the brain.
Natural resilience to major life stressors is not as common as thought
When someone goes through a rough period in their life, say a divorce or losing their job, the common thought has been that this is a test of the person's natural resilience or ability to bounce back.
New research gathers more evidence for innovative stroke treatment
New research has provided more evidence that an innovative treatment strategy may help prevent brain swelling and death in stroke patients.
How a waste product of exercise protects neurons from trauma damage
Researchers led by EPFL have found how lactate, a waste product of glucose metabolism can protect neurons from damage following acute trauma such as stroke or spinal cord injury.
UAB researchers find protein that improves mobility after spinal cord injuries
Spinal cord injuries cause severe functional disabilities in those who sustain them, including paraplegia or tetraplegia, depending on the scale of the injury.
More Spinal Cord Injury Current Events and Spinal Cord Injury News Articles